Published in Anesthesiology on September 01, 2003
Brain regions associated with the expression and contextual regulation of anxiety in primates. Biol Psychiatry (2005) 1.76
Ketamine as a novel antidepressant: from synapse to behavior. Clin Pharmacol Ther (2011) 1.34
Inhibition of NMDARs in the Nucleus Reticularis of the Thalamus Produces Delta Frequency Bursting. Front Neural Circuits (2009) 1.28
Optogenetic stimulation of infralimbic PFC reproduces ketamine's rapid and sustained antidepressant actions. Proc Natl Acad Sci U S A (2015) 1.23
Effects of neonatal amygdala or hippocampus lesions on resting brain metabolism in the macaque monkey: a microPET imaging study. Neuroimage (2007) 1.11
Baseline CBF, and BOLD, CBF, and CMRO2 fMRI of visual and vibrotactile stimulations in baboons. J Cereb Blood Flow Metab (2010) 1.05
Estimation of the regional cerebral metabolic rate of oxygen consumption with proton detected 17O MRI during precision 17O2 inhalation in swine. J Neurosci Methods (2009) 0.93
Mapping the central effects of ketamine in the rat using pharmacological MRI. Psychopharmacology (Berl) (2006) 0.93
Spatial nonuniformity of the resting CBF and BOLD responses to sevoflurane: in vivo study of normal human subjects with magnetic resonance imaging. Hum Brain Mapp (2008) 0.91
Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation. Neuroscience (2010) 0.87
A case of posterior reversible encephalopathy syndrome after emergence from anesthesia. J Anesth (2011) 0.82
Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge. Br J Med Med Res (2012) 0.82
Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit. Psychopharmacology (Berl) (2010) 0.82
Functional neuroimaging of the baboon during concurrent image-guided transcranial magnetic stimulation. Neuroimage (2011) 0.82
"Resting" CBF in the epileptic baboon: correlation with ketamine dose and interictal epileptic discharges. Epilepsy Res (2008) 0.82
Modulation of fronto-cortical activity by modafinil: a functional imaging and fos study in the rat. Neuropsychopharmacology (2011) 0.82
Functional PET Evaluation of the Photosensitive Baboon. Open Neuroimag J (2011) 0.80
Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans. J Neural Transm (Vienna) (2007) 0.80
Ketamine does not increase intracranial pressure compared with opioids: meta-analysis of randomized controlled trials. J Anesth (2014) 0.79
Contributions of experimental psychiatry to research on the psychosis prodrome. Front Psychiatry (2013) 0.78
Modulatory effects of ketamine, risperidone and lamotrigine on resting brain perfusion in healthy human subjects. Psychopharmacology (Berl) (2015) 0.78
Species-conserved reconfigurations of brain network topology induced by ketamine. Transl Psychiatry (2016) 0.77
Repetitive transcranial magnetic stimulation elicits rate-dependent brain network responses in non-human primates. Brain Stimul (2013) 0.77
Sedation and analgesia in children with developmental disabilities and neurologic disorders. Int J Pediatr (2010) 0.76
Phenomenologically distinct psychotomimetic effects of ketamine are associated with cerebral blood flow changes in functionally relevant cerebral foci: a continuous arterial spin labelling study. Psychopharmacology (Berl) (2015) 0.76
Dissociable effects of antipsychotics on ketamine-induced changes in regional oxygenation and inter-regional coherence of low frequency oxygen fluctuations in the rat. Neuropsychopharmacology (2014) 0.76
Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats. Transl Psychiatry (2017) 0.75
Ketamine modulates fetal hemodynamic and endocrine responses to umbilical cord occlusion. Physiol Rep (2016) 0.75
Ketamine Suppresses the Ventral Striatal Response to Reward Anticipation: A Cross-Species Translational Neuroimaging Study. Neuropsychopharmacology (2015) 0.75
Evaluating anesthetic protocols for functional blood flow imaging in the rat eye. J Biomed Opt (2017) 0.75
Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action. Behav Pharmacol (2017) 0.75
Subchronic memantine induced concurrent functional disconnectivity and altered ultra-structural tissue integrity in the rodent brain: revealed by multimodal MRI. Psychopharmacology (Berl) (2013) 0.75
Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study. Am J Psychiatry (2002) 3.49
Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab (2011) 3.40
Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol (2008) 2.24
Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol (2008) 2.19
Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. Int J Radiat Oncol Biol Phys (2004) 1.93
Neurological symptoms and natural course of xeroderma pigmentosum. Brain (2008) 1.78
18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer. J Nucl Med (2008) 1.77
Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology (2003) 1.70
Effects of surgical levels of propofol and sevoflurane anesthesia on cerebral blood flow in healthy subjects studied with positron emission tomography. Anesthesiology (2002) 1.62
The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects. Eur J Nucl Med Mol Imaging (2008) 1.55
Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. Anesthesiology (2006) 1.52
The breakdown of fractal heart rate dynamics predicts prolonged postoperative myocardial ischemia. Anesth Analg (2004) 1.47
Consciousness lost and found: subjective experiences in an unresponsive state. Brain Cogn (2011) 1.46
Feasibility and cardiac safety of inhaled xenon in combination with therapeutic hypothermia following out-of-hospital cardiac arrest. Crit Care Med (2013) 1.45
Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol (2003) 1.42
Absorption, distribution and excretion of intravenously injected (68)Ge/ (68)Ga generator eluate in healthy rats, and estimation of human radiation dosimetry. EJNMMI Res (2015) 1.38
Returning from oblivion: imaging the neural core of consciousness. J Neurosci (2012) 1.34
Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication. Arch Neurol (2008) 1.31
Characteristics of two telephone screens for cognitive impairment. Dement Geriatr Cogn Disord (2002) 1.31
Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain (2003) 1.29
Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes. Diabetes (2002) 1.19
S-ketamine anesthesia increases cerebral blood flow in excess of the metabolic needs in humans. Anesthesiology (2005) 1.19
Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol (2004) 1.17
Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord (2008) 1.15
Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man. Psychopharmacology (Berl) (2005) 1.14
Sensory dysfunction in burning mouth syndrome. Pain (2002) 1.13
Salivary gland cancer in Finland 1991--96: an evaluation of 237 cases. Acta Otolaryngol (2005) 1.13
Bioavailability of dexmedetomidine after intranasal administration. Eur J Clin Pharmacol (2011) 1.12
High intensity exercise decreases global brain glucose uptake in humans. J Physiol (2005) 1.11
Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain. Eur J Nucl Med Mol Imaging (2014) 1.11
Altered dopamine D2 receptor binding in atypical facial pain. Pain (2003) 1.10
Increased brain fatty acid uptake in metabolic syndrome. Diabetes (2010) 1.10
Validation of indirect calorimetry for measurement of energy expenditure in healthy volunteers undergoing pressure controlled non-invasive ventilation support. J Clin Monit Comput (2011) 1.08
Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain. Mol Imaging Biol (2006) 1.07
Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study. Mov Disord (2006) 1.05
Pain assessment tools for unconscious or sedated intensive care patients: a systematic review. J Adv Nurs (2009) 1.05
Validation of [(11) C]ORM-13070 as a PET tracer for alpha2c -adrenoceptors in the human brain. Synapse (2015) 1.05
Skeletal muscle blood flow and oxygen uptake at rest and during exercise in humans: a pet study with nitric oxide and cyclooxygenase inhibition. Am J Physiol Heart Circ Physiol (2011) 1.04
Regulation of human skeletal muscle perfusion and its heterogeneity during exercise in moderate hypoxia. Am J Physiol Regul Integr Comp Physiol (2010) 1.04
Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients. Crit Care (2011) 1.04
Comparison of exogenous adenosine and voluntary exercise on human skeletal muscle perfusion and perfusion heterogeneity. J Appl Physiol (1985) (2009) 1.03
Mobile phone affects cerebral blood flow in humans. J Cereb Blood Flow Metab (2006) 1.03
Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease. Mov Disord (2004) 1.03
Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio. Eur J Nucl Med Mol Imaging (2002) 1.02
Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility. J Cereb Blood Flow Metab (2008) 1.02
Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease. Neurobiol Aging (2005) 1.02
Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease. J Clin Psychopharmacol (2002) 1.01
Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report. Gen Hosp Psychiatry (2006) 1.01
Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region. J Cereb Blood Flow Metab (2006) 1.00
C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.00
Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid-beta accumulation. J Alzheimers Dis (2008) 0.98
Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups. Drugs Aging (2011) 0.98
Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry (2005) 0.97
Insulin- and exercise-stimulated skeletal muscle blood flow and glucose uptake in obese men. Obes Res (2003) 0.97
Why does bispectral index monitoring not perform better? Anesthesiology (2013) 0.97
Effects of a 902 MHz mobile phone on cerebral blood flow in humans: a PET study. Neuroreport (2003) 0.97
Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects. Neuroimage (2008) 0.96
Cognitive functions in relation to MRI findings 30 years after traumatic brain injury. Brain Inj (2005) 0.96
Age-related loss of extrastriatal dopamine D(2) -like receptors in women. J Neurochem (2002) 0.96
Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs. Eur J Nucl Med Mol Imaging (2012) 0.95
Defective liver disposal of free fatty acids in patients with impaired glucose tolerance. J Clin Endocrinol Metab (2004) 0.95
Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain. Eur J Neurosci (2004) 0.94
The quality of GP consultation in two different salary systems. Scand J Prim Health Care (2004) 0.94
Dopaminergic effects of caffeine in the human striatum and thalamus. Neuroreport (2004) 0.94
Effects of subanesthetic ketamine on regional cerebral glucose metabolism in humans. Anesthesiology (2004) 0.94
Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients. Stroke (2004) 0.93
Visual assessment of [(11)C]PIB PET in patients with cognitive impairment. Eur J Nucl Med Mol Imaging (2010) 0.93
Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain (2002) 0.93